Skip to main content
Log in

The pharmacokinetics of ketoconazole after chronic administration in adults

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

We have studied the pharmacokinetics of the anti-mycotic ketoconazole in seven patients who took it for 1–6 months at a dose of 200 mg daily.

The mean elimination half-life of the drug was 3.3 h, and although the ketoconazole was given only once daily, a satisfactory clinical response was obtained in all seven individuals. Only a small fraction of the absorbed drug (mean 0.22%) was excreted unchanged in the urine, suggesting almost complete metabolism.

Our results support the concept that anti-mycotic activity in the tissues continues after the plasma drug concentration has fallen below a critical level. Our results also support the concept of a change in pharmacokinetics with chronic dosing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Badcock NR (1984) Micro-determination of ketoconazole in plasma or serum by high-performance liquid chromatography. J Chromatogr 306: 436–440

    Google Scholar 

  • Baxter JG, Brass C, Schentag JJ, Slaughter RL (1986) Pharmacokinetics of ketoconazole administered intravenously to dogs and orally as tablet and solution to humans and dogs. J Pharm Sci 75: 443–447

    Google Scholar 

  • Borgers M (1980) Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. Rev Infect Dis 2: 520–534

    Google Scholar 

  • Brass C, Galgiani JN, Blaschke TF, Defelice R, O'Reilly RA, Stevens DA (1982) Disposition of ketoconazole, an oral antifungal, in humans. Antimicrob Agents Chemother 21: 151–158

    Google Scholar 

  • Brown RD, Manno JE (1978) ESTRIP, a basic computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci 67: 1687–1691

    Google Scholar 

  • Daneshmend TK, Warnock DW, Turner A, Roberts CJC (1981) Pharmacokinetics of ketoconazole in normal subjects. J Antimicrob Chemother 8: 299–304

    Google Scholar 

  • Daneshmend TK, Warnock DW, Ene MD, Johnson EM, Parker G, Richardson MD, Roberts CJC (1983) Multiple dose pharmacokinetics of ketoconazole and their effects on antipyrine kinetics in man. J Antimicrob Chemother 12: 185–188

    Google Scholar 

  • Daneshmend TK, Warnock DW, Ene MD, Johnson EM, Potten MR, Richardson MD, Williamson PJ (1984) Influence of food on the pharmacokinetics of ketoconazole. Antimicrob Agents Chemother 25: 1–3

    Google Scholar 

  • Drouhet E, Dupont B (1983) Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. Am J Med 74: 30–47

    Google Scholar 

  • Gascoigne EW, Barton GJ, Michaels M, Meuldermans W, Heykants J (1981) The kinetics of ketoconazole in animals and man. Clin Res Rev 1: 177–187

    Google Scholar 

  • Graybill JR, Lundberg D, Donovan W, Rodriguez MD, Drutz DJ (1980) Treatment of coccidioidomycosis with ketoconazole: Clinical and laboratory studies of 18 patients. Rev Infect Dis 2: 661–673

    Google Scholar 

  • Haneke E (1985) Tissue concentrations of ketoconazole after treatment. In: Meinhof W (ed) Oral therapy in dermatomycoses: A step forward. Proceedings of a symposium, Frankfurt, FRG, February 1985. The Medicine Publishing Foundation Symposium Series No. 16, pp 71–72

  • Hawkins Van Tyle J (1984) Ketoconazole. Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use. Pharmacotherapy 4: 343–373

    Google Scholar 

  • Heel RC, Brogden RN, Carmine A, Morley PA, Speight TM, Avery GS (1982) Ketoconazole: A review of its therapeutic efficacy in superficial and systemic fungal infections. Drugs 23: 1–36

    Google Scholar 

  • Heykants J et al. (1980) Janssen Pharmaceutica, Clinical Research Report, R 41400/26

  • Huang YC, Colaizzi JL, Bierman RH, Woestenborghs R, Heykants J (1986) Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers. Antimicrob Agents Chemother 30: 206–210

    Google Scholar 

  • Maksymiuk AW, Levine HB, Bodey GP (1982) Pharmacokinetics of ketoconazole in patients with neoplastic diseases. Antimicrob Agents Chemother 22: 43–46

    Google Scholar 

  • Männistö PT, Mäntylä R, Nykänen S, Lamminsivu U, Ottoila P (1982) Impairing effect of food on ketoconazole absorption. Antimicrob Agents Chemother 21: 730–733

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Badcock, N.R., Bartholomeusz, F.D., Frewin, D.B. et al. The pharmacokinetics of ketoconazole after chronic administration in adults. Eur J Clin Pharmacol 33, 531–534 (1987). https://doi.org/10.1007/BF00544251

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00544251

Key words

Navigation